Clinical Trial Update: Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers [Phase 1, Phase 2]

View source ↗

Summary

Phase I/IIa clinical trial update for BR1733 in advanced cancers, including follicular lymphoma, peripheral T-cell lymphoma, and diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• BR1733

Snippet

Sponsor: Shanghai Blueray Biopharma Co., Ltd. | Conditions: Advanced Cancer, Follicular Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING